Jim Tananbaum is someone whose name constantly pops up in conversations involving healthcare innovation. He is an entrepreneur and investor who specialize in healthcare. He has been an industry leader for close to three decades and still counting. He is founder and CEO of Foresite Capital, a venture capital and private growth equity firm primarily focused on healthcare. It supplies rising healthcare companies with capital, networks, and information.
In a report by Biz Journals, when Tananbaum founded Foresite Capital in 2011, he drew on his vast experience as a healthcare entrepreneur and investment strategist to make the company stand out from others in the industry. He accurately chooses emerging healthcare leaders by identifying key success factors that often go unnoticed.
He hopes to harness healthcare’s future by using Foresite Capital as a conduit to achieve his goal. Foresite has invested in more than 70 healthcare startups in many different areas of the industry including biopharmaceuticals, medical services, diagnostics and genomic sequencing.
According to INC42, Tananbaum was able to find quick success with Foresite Capital because of prior experience as a company owner. He already founded four companies in healthcare before founding Foresite Capital. Two of which were leading biopharmaceutical companies. While still in college he founded GelTex Pharmaceuticals (NASDAQ:GENZ). The company became very profitable faster than most expected bringing two drugs to market for less than $80 million. It was eventually sold for $1.6 billion.
Jim Tananbaum is a bit of a scholar. He boasts a M.D. and M.B.A. from Harvard, a M.S. from the Massachusetts Institute of Technology, and was a math and electrical engineering/computer science major at Yale. He has been mentored by multiple leading academicians.
As an entrepreneur Tananbaum is a calculating risk taker who makes sure he fully understands the situation beforehand. He is a doer who never quits. Despite his shortcomings he always remains optimistic and diligent.